Bespoke Extracts (BSPK) Cost of Revenue (2018 - 2025)
Bespoke Extracts' (BSPK) quarterly Cost of Revenue came in at $233770.0 in Q3 2025, up 43.88% year-on-year from $162476.0 in Q3 2024, and up 21.09% quarter-over-quarter from $193054.0 in Q2 2025.
Bespoke Extracts (BSPK) Cost of Revenue (2018 - 2025) Analysis & Trends
Bespoke Extracts has disclosed Cost of Revenue across 8 years of filings, most recently posting $233770.0 for Q3 2025.
- Cost of Revenue for Q3 2025 came in at $233770.0, up 43.88% year-over-year; the trailing twelve-month figure through Sep 2025 was $751352.0 (up 26.75% YoY), and the FY2024 annual result was $664517.0, up 50.24% from the prior year.
- Cost of Revenue came in at $233770.0 for Q3 2025 at Bespoke Extracts, up from $193054.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $233770.0 in Q3 2025 to a low of -$46431.0 in Q4 2022.
- The 5-year median for Cost of Revenue is $100411.0 (2023), against an average of $89824.2.
- Across the five-year window, Cost of Revenue decreased 8.94% in 2021 and soared 224515.38% in 2023, its largest moves.
- Bespoke Extracts' Cost of Revenue stood at $1864.0 in 2021, then tumbled by 2590.93% to -$46431.0 in 2022, then jumped by 316.26% to $100411.0 in 2023, then surged by 71.44% to $172148.0 in 2024, then soared by 35.8% to $233770.0 in 2025.
- The last three Cost of Revenue figures came in at $233770.0 (Q3 2025), $193054.0 (Q2 2025), and $152380.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 | 233,770.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 233,770.00 |
| Sep 30, 2025 | 233,770.00 |
| Jun 30, 2025 | 193,054.00 |
| Jun 30, 2025 | 193,054.00 |
| Mar 31, 2025 | 152,380.00 |
| Mar 31, 2025 | 152,380.00 |
| Dec 31, 2024 | 172,148.00 |
| Dec 31, 2024 | 172,148.00 |
| Sep 30, 2024 | 162,476.00 |
| Sep 30, 2024 | 162,476.00 |
| Jun 30, 2024 | 172,046.00 |
| Jun 30, 2024 | 172,046.00 |
| Mar 31, 2024 | 157,847.00 |
| Mar 31, 2024 | 157,847.00 |
| Dec 31, 2023 | 100,411.00 |
| Dec 31, 2023 | 100,411.00 |
| Sep 30, 2023 | 146,000.00 |
| Sep 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 117,211.00 |
| Jun 30, 2023 | 117,211.00 |